Background: Delirium--a costly, life-threatening, and potentially preventable condition--is a
INTRODUCTION
Delirium, an acute decline of cognition and attention, is a common, costly, lifethreatening, and potentially preventable problem for older persons (Inouye 2006 , Marcantonio 2011 . The most common complication of hospitalization and surgery, 15-53% of surgical patients develop delirium (Inouye 2006 NEJM, Rudolph 2011 , which increases the risk of morbidity, functional decline, nursing home admission, prolonged length of hospital stay, and mortality (Inouye 2006 , Witlox 2010 Despite its obvious clinical and health policy ramifications, the etiology and long-term outcomes of delirium remain poorly understood. Delirium has been independently associated with long-term functional decline in a number of studies with follow-up periods ranging from 1 to 12 months in hip fracture (Dolan 2000 , Marcantonio 2000 , Olofsson 2005 , Krogseth 2011 ), medical (McCusker 2001 , Andrew 2005 , Buurman 2011 , and long-term care (Kiely 2006) patients. In another 4 studies, delirium did not demonstrate a significant impact on long-term functional outcomes at 3 months to 2 years follow-up (Furlaneto 2007 , Zakriya 2004 , Vida 2006 , Katz 2001 . However, these studies have inconsistent results and many are limited by high attrition rates, infrequent follow-up, inclusion of moderate to severe dementia patients, lack of baseline pre-delirium assessment, lack of follow-up neuropsychological testing, and inadequate control for competing causes of cognitive decline.
Whether delirium contributes independently to long-term or permanent cognitive impairment remains unclear. Delirium symptoms can persist for months to years (Levkoff 1992 , 1994 , Marcantonio 2000 , Cole 2003 , 2009 Age Aging, Kiely 2009 . Some causes of delirium, such as prolonged hypoxia or hypoglycemia, may lead to irreversible cognitive impairment (Inouye 1997) . Neuroimaging studies (Yokota 2003 , Fong 2006 suggest that delirium may incite a derangement in brain vascular function that could lead to dementia in some cases. The entities of persistent delirium (Marcanontio 2000 , Inouye 2007 , Kiely 2009 ) and reversible dementia (Clarfield 1988) blur the boundaries between these conditions. Moreover, delirium may herald the onset of dementia in some cases, recognized with frequent examples by clinicians and family members who point to the delirium as "the beginning of the end".
To address these gaps in knowledge, a group of interdisciplinary investigators launched a program project-Successful Aging after Elective Surgery (SAGES)-funded by the National Institute on Aging that aims to elucidate novel risk markers (including biomarkers, neuroimaging and reserve markers) and to examine the contribution of delirium to long-term cognitive and functional decline. The program project grant (P01) mechanism is complex in scope and is intended to fund synergistic research designed to achieve results not attainable by investigators working independently (Ref: NIH website) . This mechanism is particularly suited for interdisciplinary investigators who wish to collaborate around a set of closely related projects addressing a well-defined scientific problem. The present study is well-suited for this mechanism and provides substantial advances over previous work, including the state-of-the-art measurement of delirium and cognitive decline, large sample size, baseline pre-delirium assessment, frequent follow-up up to 36 months, and careful examination of competing cause of long-term cognitive decline. This program project provides an unprecedented opportunity to examine the etiology of this complex multifactorial geriatric syndrome. Upon completion, it will provide the unique resources of a clinically rich database on a well-characterized cohort of 550 older persons prior to hospitalization or surgery with long-term follow-up (18-36 months), a library of advanced neuroimaging scans, and a biorepository of blood and genetic material.
Ultimately, we anticipate that this study will lay the groundwork to develop more effective prognostic, preventive and treatment approaches for delirium following major surgery.
Conceptual Framework
A unifying conceptual framework for the study appears in Figure 1 . Given the multifactorial nature of delirium, the investigation involves interdisciplinary approaches to clarify its epidemiology, risk markers, and prognosis. This study includes 4 projects which utilize the SAGES cohort and address inter-linked aims. Project 1 utilizes epidemiologic approaches to elucidate the long-term prognosis of delirium, specifically, its contributions to cognitive and functional decline. Project 2 uses laboratory approaches including multiplex analysis of cytokines and quantitative proteomics for discovery of biomarkers related to delirium. Project 3 employs advanced neuroimaging methods to identify imaging markers for delirium, and to evaluate whether long-term neuroimaging changes (such as atrophy) are associated with delirium. Project 4 will examine the role of cognitive and brain reserve in development and long-term outcomes of delirium. All of these projects will utilize the SAGES study cohort, and will address inter-linked aims.
METHODS

Overview
This 5-year prospective observational study examines 550 older patients prior to their scheduled surgery. Patients are enrolled in the community, interviewed daily during the initial hospitalization and surgery, and followed prospectively for a minimum of 18 months and up to including serial neuropsychological testing and physical functioning measures. Phlebotomy is performed at baseline, in the hospital (immediate post-operative and hospital day two) and at one-month after discharge. Approximately one-third of the sample will receive MRI brain scans at baseline and one year later.
Eligibility
Study inclusion and exclusion criteria appear in Table 1 Patient aged 70 or older who are scheduled for an elective surgical procedures with a moderate-to-high risk (>25%) of delirium are considered eligible (Balasundaram 2007 , Benoit 2005 , Bohner 2003 , Galanakis 2001 , Ganai 2007 , Kudoh 2004 , Mann 2000 , Marcanontio/Goldman 1994 , Olin 2005 , Sampson 2007 , Schneider 2002 , Ushida 2009 , Bryson 2011 , Salata 2012 , Flink 2012 . Patients with active delirium or clinically recognized dementia are excluded. Dementia screening occurs at three levels: during initial medical record screening, Patients with a score of <69 or its education-adjusted equivalent on the Modified Mini-Mental (3MS) test during the baseline interview are also excluded (Tombaugh 1996) . At the end of the baseline interview, patients are assessed with the Confusion Assessment Method (CAM) for evidence of delirium and are excluded if delirium is present (Inouye 1990) . Detailed eligibility and exclusion criteria along with the associated procedures are indicated in Table 1 . All study procedures were approved by the Institutional Review Boards at the two clinical sites (BIDMC, BWH), and Hebrew Senior Life (HSL).
All patients who are found to be study eligible are rescreened by a second staff member before they are invited to participate in the study. To ensure high quality of all eligibility screening procedures, random re-checks of screening are conducted on a monthly basis.
Recruitment
Informed by a feasibility study with high risk older adults to identify barriers to participation in long-term clinical research (Marcantonio 2008) , recruitment and data collection procedures for SAGES include home-based assessments of less than 75 minute duration and free parking for all hospital-based activities. Only patients whose surgeons provided written approval to contact their patients are approached (86% of all eligible surgeons). The study staff reviews the BIDMC and BWH operating room advanced booking schedules twice weekly to identify eligible patients (Table 1) . Patients who meet eligibility criteria receive a letter co-signed by their surgeon and study investigators inviting them to participate in the study. Eligible patients are contacted by telephone to explain the study and confirm eligibility. Subsequently, patients are scheduled for a face-to face baseline screening and assessment in their own home or location of their choice. During the baseline interview, eligible patients are offered participation in the MRI sub-study with a separate screening and consent procedure. Study enrollment is confirmed once an eligible surgery has been completed, and the operative date represents the zero-time for this prospective cohort study.
Study Assessments and Schedule
Interviews. Study participants undergo a baseline assessment prior to the index hospitalization, including neuropsychological screening and functional assessment. During the index hospitalization, patients are assessed daily for the development of delirium from the day after surgery until the day of discharge. After discharge, patients are followed with home-based interviews at 1 month, 2 months, and every 6 months up to 36 months to evaluate for all primary and secondary outcomes. Brief telephone interviews are conducted in between face-to-face interviews at 4, 9, 15, 21, and 27 months to assess for hospitalizations. At baseline and every six months after the index hospitalization, proxies are interviewed by telephone for proxy ratings of cognitive and functional status and to report on hospitalizations. Medical records are reviewed at the end of the index hospitalization and after each subsequent hospitalization up to 18-36 months to identify recurrent delirium and new illnesses. Table 2 lists all outcomes variables and the study assessment schedule.
All study interviews are conducted by experienced, carefully trained and standardized clinical interviewers, who undergo 2-4 weeks of intensive training. Each trainee is instructed by an expert interviewer on how to administer questionnaires, then the trainee practices with peers and older adult volunteers. Once comfortable, trainees shadow an expert during 4-5 interviews with patients, and then trainees perform 4-5 interviews under observation by the expert interviewer. Both the trainee and expert score the interview, and after each shadowing session the trainee and expert discuss and resolve discrepancies. The training continues until a trainee has conducted two consecutive interviews without errors. Inter-rater reliability assessment and standardization on all key study variables is conducted every 6 months continually throughout the study. In addition, coding questions are addressed in weekly meetings of all study staff.
Medical Record Review.
As an initial step, medical records are reviewed for eligibility screening (Table 1) . After discharge from the index hospitalization, a comprehensive medical record abstraction is then conducted to provide information on the surgical procedure, anesthesia type and duration, baseline diagnoses and comorbidity, abnormal laboratory results, development of delirium, precipitating factors for delirium (e.g., medications, iatrogenic events, catheters or physical restraints), postoperative complications, intercurrent illnesses, and death. Subsequently, when information on rehospitalization is obtained at any follow-up interview (patient or proxy), a chart review is completed to assess for recurrent delirium and inter-current illnesses. Interreliability assessment on chart review is conducted on 10% of the sample.
Delirium Assessment
All 4 component projects of the program project use delirium as a major predictor, key outcome, or control variable. Delirium is assessed prospectively at baseline, daily during the index hospitalization, and at each follow-up interview based on information from the patient interview, 3MS (baseline) or brief cognitive screen (hospital, all follow-ups), digit span testing, Confusion Assessment Method (CAM), and Delirium Symptom Interview (DSI). The Delirium Symptom Interview (DSI, Albert 1992) is a brief instrument that is used specifically to determine the presence or absence of 8 key features of delirium and to inform the CAM rating. The presence of delirium is determined by fulfillment of the validated Confusion Assessment Method (CAM) diagnostic algorithm (Inouye 1990) . The CAM provides a widely used standardized method for identification of delirium, which has been demonstrated to have a sensitivity of 94% (95% confidence interval [CI] 91-97%), specificity of 89% (95% CI 85-94%), and inter-rater reliability of 0.70 to 1.00 in studies involving over 1,070 patients (Wei 2008) . The methods for delirium identification used in this study have been widely applied and demonstrated to have high reliability in previous studies (Inouye 1999 , Simon 2006 . Delirium by interviewer rating (CAM criteria) is further augmented with a validated delirium assessment from medical record review during the index hospitalization (Inouye 2005) , since delirium fluctuates and may occur between interviews. Delirium severity is rated with the widely-used Memorial Delirium Assessment Scale (Brietbart 1997), a 10-item scale that uses information from cognitive testing and structured observations to rate delirium severity. Each item is rated as 0-3, to generate a 0-30 scale (30=most severe).
Delirium duration is defined as the total number of delirium-days with positive CAM rating during the index hospitalization. Delirium recurrence is defined as the total number of delirium episodes, which must be separated in time by at least 48 hours. Persistent delirium is assessed with a face-to-face or telephone interview 2 weeks after hospital admission in patients who had delirium during index hospitalization. Recurrent and persistent delirium will be handled as time-varying covariates in secondary analyses.
Primary Outcomes
The primary long-term outcomes for the program project include cognitive performance and physical functioning variables. These outcomes are assessed by a separate follow-up team who are blinded to the patient's delirium status during hospitalization.
General Cognitive Performance (GCP) Composite. A General Cognitive Performance
(GCP) composite was created for this study. The GCP represents a combination of neuropsychological measures, and will be applied in our analyses as a continuous outcome measure (Jones 2010) . The complete neuropsychological test battery is described in Table 3 The GCP has excellent psychometric properties with minimal ceiling and floor effects across as broad range of values (Jones 2010). While the GCP will be the primary cognitive outcome measure, we will also examine domain-specific effects, looking at both individual neuropsychological tests and combinations of cognitive domains (for example, attention, executive functioning, memory, language). Since the effects of delirium may not be uniform across all domains, these analyses will help to determine if certain aspects of cognitive functioning, such as executive function and attention, are more susceptible to the detrimental long-term effects of delirium than others, such as memory and language.
Physical Functioning. The physical functioning measures for this study include the basic Activities of Daily Living Scale (ADLs, Katz 1963) , Instrumental Activities of Daily Living Scale (IADLs, Lawton 1969) , and the physical functioning domain of the Short Form Health Survey (SF-12, Ware 1992) at baseline, 1 month, 2 months, 6 months and every 6 months thereafter. The ADL scale assesses the ability to perform 7 basic care skills (feeding, bathing, dressing, grooming, using the toilet, transferring, and walking), with each activity scored from 0 (unable) to 2 (without help). The IADL scale assesses the ability to perform 7 complex activities (using the telephone, grocery shopping, using transportation, cooking, housekeeping, taking medications, and handling finances). The SF-12 is a multi-dimensional health outcomes assessing: health, social functioning, role-emotional, and physical and mental health (Ware 1996) ; the physical function domain of the SF-12 will be used as a primary study outcome. These variables will be examined individually, and also as a composite measure.
Secondary Outcomes
Secondary outcomes include re-hospitalization, institutionalization, death, and incident dementia or mild cognitive impairment by clinical consensus rating. Information about rehospitalization, institutionalization, and death will be obtained from patient and family interviews and medical record reviews. The time and cause of death will be obtained from medical record review and confirmed with information from the National Death Index. agreement of >5 of 7 panel members. The CCP also reviews major intervening events to determine if these may be associated with cognitive decline (e.g., major stroke) independent of delirium.
Clinical Consensus
Additional Study Variables
Additional variables to be collected for this study are indicated in Table 4 . These include key risk factors and co-variables for analyses. Further detail on novel risk factors-plasma biomarkers, imaging markers, and reserve markers-is provided below.
Plasma Biomarkers for Delirium. This program project aims to discover plasma biomarkers related to delirium risk, delirium incidence and duration utilizing multiplex analysis to describe cytokine and plasma protein "signatures". Blood is collected from the entire cohort at 4 time points: a) at the time of the baseline study assessment, b) immediately after surgery in the post-anesthesia care unit, c) on postoperative day two, and d) one-month after surgery. The biomarker discovery process will involve comparing specimens of patients who develop delirium during their index hospitalization with those of matched patients who do not. The relationship of the cytokine and protein signatures with long-term cognitive and functional outcomes will also be examined.
Imaging Markers for Delirium. Magnetic resonance imaging (MRI) of the brain will be used to discover risk and disease markers associated with delirium through volumetric, white matter hyperintensity, noncontrast blood flow, diffusion and diffusion tensor measures to characterize the functional and structural effects of delirium in the brain by comparing patients who develop delirium with patients who do not. A subgroup of 150 patients who pass the MRI eligibility screen (i.e., no contraindicated implants or metal fragments in the body, or claustrophobia) are imaged on the same 3 Tesla MRI scanner at baseline before the initial surgery and again at 12 months after the surgery. The baseline measure will be used to identify potential imaging risk markers for delirium. The follow-up scans will be used to evaluate for long-term changes associated with the development of delirium.
Reserve Markers for Delirium. The program project will examine the role of cognitive and brain reserve, a measure of the resilience of the brain to withstand neuropathological damage, on the occurrence and consequences of delirium. A multifaceted model for reserve in delirium will be created to determine whether higher reserve is independently associated with a lower rate of incident delirium and less long-term cognitive and functional decline.
Incorporating a life course perspective, reserve markers include education and occupation (self and parental), lifetime cognitive activities, physical and social activities, pre-morbid intelligence, head circumference and brain volume.
Research Resources. The study data and materials will provide a unique, clinicallydetailed, longitudinal resource on older patients undergoing hospitalization and major surgery.
Moreover, the bio-repository of genetic material and plasma will be a resource for future investigation including additional biomarker discovery studies.
Data Management and Analysis
A database management system has been developed to track a participant's status throughout the course of the study, to produce timelines for interviewers, and for continuous quality assessment and progress reports. We use a combination of electronic data capture (EDC) and paper data collection procedures. We use RedCAP [Harris, 2009 #5858] for web-based data collection and Pepper Informatics [Brandt, 2004 #5922] for PC-based data collection. We use EDC wherever feasible but use paper forms when a written record is desired (e.g., neuropsychological testing) or when we cannot be assured that interviewers will have internet access (e.g., hospital floors, patients' homes).
Data management includes daily integration of EDC and paper forms, email notifications of pending visits and scheduling information, and development of an interim project database for preliminary analyses. According to our study schedule, we periodically institute data freezes on a sample with verified and cleaned data (i.e., double data entry and consistency checks evaluated and resolved). Frozen data files are used for interim reports, drafting analysis plans and mock tables to address project aims, and preliminary abstracts and manuscripts on study methods. The analysts and investigators remain blinded to the main study hypotheses through use of a random, blinded variable for delirium status.
Statistical Considerations. Sample size was determined by balancing many factors. First, we considered feasibility of patient accrual within the planned enrollment period. Second, we wanted to restrict our pool of eligible surgeries to those with a moderate-to-high delirium risk.
Being more restrictive produces a more homogeneous patient sample, but limits accrual. We also considered our other eligibility criteria, and their impact on feasibility, delirium risk, and statistical power. Each of the four projects has its own aims and hypotheses, some using the entire expected sample, and some using a limited subset. We verified adequate sample size to test each hypothesis with calculations based on pilot data or previous published studies. We determined that a sample of 550 patients, with an anticipated incidence of postoperative delirium of 25%, would be adequate to address the needs of the aims of all 4 projects. In addition, we are recruiting a sample of 120 non-surgical participants from primary care clinics at BIDMC who will provide normative data on neuropsychological test performance and the impact of retest effects on estimated test scores.
Study Management
The Program Project includes 3 study cores to support the 4 projects: Administrative, Epidemiology, and Data Cores. Well-coordinated meetings are held between all Cores and Projects for ongoing scientific exchange and procedural clarification. The Administrative Core meets weekly to provide overall leadership for the project, assure adherence to study timelines, complete required progress reports, and address all institutional review and human subjects compliance issues. The Epidemiology Core leaders and staff hold weekly meetings to address questions from the field team (coding, participant issues, and scheduling). The Data Management and Analysis Core leaders and staff meet weekly to discuss ongoing data tracking, quality, and analysis issues. In addition, specific project analysis meetings are held on a bimonthly basis to advance the primary aims of each project.
Executive Committee. The Executive Committee, the main decision-making group for the program project consists of all project and core leaders, clinical experts, and the study project director, meets twice monthly to optimize scientific integration and productivity. Subcommittees Operations Committee. Study policies, operations, and management issues are addressed during weekly operation meetings attended by all core leaders, co-leaders, and project directors.
A detailed Operations and Procedures Manual was developed during study initiation and is regularly updated with decisions made at these meetings. The manual and updates (indexed by date and topic) are posted on a password-protected study website, accessible to all study investigators and staff.
Other Administrative Elements. A Scientific Advisory Board consisting of 6 interdisciplinary experts (anesthesiology, cognitive neuroscience-reserve, geriatric medicine, geriatric nursing, pulmonary medicine-biomarkers, and radiology) meets yearly to provide independent scientific review, monitor progress, and provide ongoing direction and input for the study investigators. Meetings with the Safety Officer are held semiannually to ensure the protection of human subjects. All adverse events and deviations are reported to the Safety Officer on a regular basis. The Fiscal Management Committee meets monthly to ensure fiscal accountability and budget tracking.
DISCUSSION
Over two decades of delirium research have done much to increase our ability to diagnose this previously under-recognized disorder. Previous studies have also identified strategies for decreasing the incidence and impact of delirium for certain patient populations.
Nevertheless, the toll that delirium takes on older patients, and on healthcare spending, remains unacceptably high. Delirium takes its toll not only during the acute episode of delirium but, in many patients, through long-term cognitive morbidity following the episode. Without further advances in the prediction, prevention, and treatment of delirium, this toll will only increase as the population of those most at risk, the elderly, continues to grow. Such advances in clinical management can only come with a better understanding of the biology and outcomes of delirium.
Recent technological advances in biomarker identification and neuroimaging offer new pathways for the discovery of the biological underpinnings of delirium. Refinements in delirium and dementia assessments have improved our ability to screen, quantify, and track delirium and dementia. Theories of brain and cognitive reserve have opened new avenues of research for interventions that might attenuate delirium and dementia. For the first time, this program project brings these advancements "under one roof" to study in a prospective, coordinated and interdisciplinary fashion the risk factors, biological markers, reserve markers, and long term cognitive effects of delirium. The logistical challenges inherent to running a large multi-project program of this nature are formidable, and this manuscript describes our response to addressing these challenges.
The benefit of running inter-linked studies of this nature, in addition to cost-effectiveness, is the opportunity to research a complex, multifactorial clinical syndrome in a prospective manner along multiple investigative fronts. Importantly, the program project also includes the creation of a biorepository of data, images, plasma, and genetic materials for future research that might inform the care of older patients undergoing major health-related stresses that will shed light on many other conditions. Moreover, the rigorous and innovative approach to address a common, complex, multifactorial clinical syndrome may be applicable across a diverse array of clinical conditions.
Methodological Considerations
In designing the program project, the investigators grappled with several key issues that may be informative to others designing similar studies or to the general audience interpreting study findings. These are described below:
1) Inclusion of Patients with Unrecognized Dementia or MCI. While we always intended
to exclude patients with clinically recognized dementia, we carefully considered whether or not to use the detailed neuropsychological testing and proxy interviews in our baseline assessment to exclude patients with more subtle dementia or mild cognitive impairment. The primary motivation for exclusion would be to have a "pure sample" without pre-existing cognitive disorders that might confound the relationship between delirium and long-term outcomes.
However, since the vast majority of older patients undergoing surgery do not undergo such detailed neuropsychological testing, our study sample would be highly selected and findings would not be generalizable to any clinical population. Ultimately, we decided not to exclude such patients, but to increase our sample size from the initially planned 500 to 550 so that we could conduct sensitivity analyses to determine whether or not the final study conclusions differ whether we include or exclude patients with mild dementia or MCI.
2) Breadth of Surgical Procedures. A second decision that we carefully considered was the breadth of surgical procedures to include in our study. We excluded cardiac surgery because of potential issues with cardiopulmonary bypass, surgeries with high mortality rate (e.g. pancreatic cancer resection) and urgent/emergency procedures where we would be unable to measure the patient's pre-surgical baseline (e.g. hip fracture repair). Among the remaining noncardiac procedures, we focused on major surgical procedures commonly performed in older adults with a hospital length of stay of at least 2 days, and with a moderate to high delirium risk (overall 25%). Including the broadest selection of such procedures would benefit the epidemiological studies (Projects 1, 4), while using a very narrow set of procedures would benefit mechanistic studies (Projects 2, 3) . In the end, we chose a compromise position, in which we are enrolling seven major types of surgery-total hip replacement, total knee replacement, lumbar laminectomy, cervical laminectomy, lower extremity vascular bypass surgery, open aortic aneurysm repair, and colectomy (open or laparoscopic). This more limited set of surgical procedures captures approximately 50% of the older surgical population, but still enables us to adjust for, stratify on, or match by surgical procedure, as is being done in Project 2.
We also considered whether to include new minimally invasive surgical procedures based on our inclusion criteria, so that some such surgeries (laparoscopic colectomy) are eligible, while others (endovascular aortic aneurysm repair) are not since these patients typically stay only 1-2 days in the hospital.
3) Isolating Effects of Delirium. Finally, we carefully considered how to separate out delirium effects from the admittedly complex perioperative milieu. Although randomized trials are considered the "gold standard" for assessing causality, it would be impossible to randomize patients to delirium or no delirium groups. Despite being observational, we believe that our study incorporates key elements that represent a significant advance over the existing literature.
These include: 1) carefully characterized baseline status of all participants, 2) detailed intraoperative and postoperative follow-up including daily hospital interviews and medical record review, 3) in-depth longitudinal follow-up with patient and proxy interviews, medical record review, and careful ascertainment of intercurrent events, and 4) incorporation of a nonsurgical comparison group. These elements will enable us to use sophisticated longitudinal analytic techniques with careful adjustment for confounders of long term outcomes, thus enabling us to mount the most sophisticated effort to date to attribute such outcomes to delirium.
Significance
This program project provides an innovative conceptualization of delirium as a potential reversible cause of cognitive and functional decline, and represents an initial step in generating novel strategies to forestall such decline in late life. Identification of cogent biomarkers, imaging, or reserve markers for delirium risk may help us target high-risk patients preoperatively-for instance with new anesthetic strategies to minimize delirium-or to follow the response of delirium to management strategies. The study of cognitive reserve may help us to identify reserve-enhancing educational, behavioral, or lifestyle strategies that can "immunize" against the development of delirium.
While we cannot anticipate our specific findings, our study's broad hypotheses are that delirium itself may be a major initiating or predisposing factor for long-term cognitive and functional decline, and that patient and hospitalization-specific factors are major determinants of the incidence of delirium. If these hypotheses are supported, then our findings would necessitate a marked shift in how delirium is addressed clinically. In fact, delirium would need to be handled as a true medical emergency in all cases, with timely interventions for recognition and treatment to prevent progressive cognitive and functional decline and related adverse outcomes.
Heightened efforts to recognize delirium would be required, along with changes in clinical management, including stopping the common practice of discharging patients who are actively delirious (Inouye DD study).
The consequences of these potential shifts in clinical care are substantial. With prevention of 30-40% of delirium cases-which may be achievable based on previous workthere is a promise of dramatic preservation of long-term cognitive health in our elderly population with all the concomitant positive repercussions to the health of the elderly, to the U.S. 
